Literature DB >> 20449712

Radical surgery for a ventricular septal defect associated with trisomy 18.

Jotaro Kobayashi1, Yukihiro Kaneko, Yuusuke Yamamoto, Hitoshi Yoda, Keiji Tsuchiya.   

Abstract

PURPOSE: Congestive heart failure is one of the major causes of early death of patients with trisomy 18. Ventricular septal defect (VSD) is the most common heart defect in patients with trisomy 18, and closure of the VSD may elongate the lifespan of the patient. Morphological characteristics of these patients, such as thoracic deformity, prominent right ventricular hypertrophy, and dysplastic tricuspid valve may complicate closure of the VSD. We report our initial experience of VSD closure in patients with trisomy 18 and estimate the feasibility of the surgical procedure.
METHODS: Between June 2005 and September 2007, five female patients with trisomy 18 and VSD underwent radical operations. Four of them had undergone previous palliative surgery entailing pulmonary artery banding.
RESULTS: All patients survived surgery. The average cardiac arrest time during surgery was 74 +/- 22 min. No early death occurred within 30 days of surgery. One patient with hydrocephalus treated by a previous ventriculoperitoneal shunt died in hospital owing to postoperative intracranial hypertension. Four of five patients were discharged from the hospital. Of the four discharged patients, a girl who underwent primary radical operation died of pneumonia. Another patient died of sudden cardiopulmonary arrest. The average survival of the patients in this study was 815 +/- 389 days at data acquisition, with two patients still alive.
CONCLUSION: Closure of VSDs in patients with trisomy 18 was found feasible and was associated with extended survival.

Entities:  

Mesh:

Year:  2010        PMID: 20449712     DOI: 10.1007/s11748-009-0431-3

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  14 in total

1.  Natural history of trisomy 18.

Authors:  N D Embleton; J P Wyllie; M J Wright; J Burn; S Hunter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

2.  Population-based analyses of mortality in trisomy 13 and trisomy 18.

Authors:  Sonja A Rasmussen; Lee-Yang C Wong; Quanhe Yang; Kristin M May; J M Friedman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

3.  Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark.

Authors:  H Goldstein; K G Nielsen
Journal:  Clin Genet       Date:  1988-12       Impact factor: 4.438

4.  Congenital polyvalvular disease in trisomy 18: echocardiographic diagnosis.

Authors:  S M Balderston; E M Shaffer; R L Washington; H M Sondheimer
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

5.  Survival in trisomy 18.

Authors:  S Root; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15

6.  Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance.

Authors:  William M Novick; Nestor Sandoval; Vasiliy V Lazorhysynets; Victor Castillo; Alexander Baskevitch; Xiomung Mo; Robert W Reid; Branko Marinovic; Thomas G Di Sessa
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

7.  [Heart malformations in trisomy 13 and trisomy 18].

Authors:  M A Lizárraga; S Mintegui; J Sánchez Echániz; J M Galdeano; E Pastor; A Cabrera
Journal:  Rev Esp Cardiol       Date:  1991-11       Impact factor: 4.753

8.  Intensive cardiac management in patients with trisomy 13 or trisomy 18.

Authors:  Yukihiro Kaneko; Jotaro Kobayashi; Yusuke Yamamoto; Hitoshi Yoda; Yuki Kanetaka; Yayohi Nakajima; Daiichi Endo; Keiji Tsuchiya; Hajime Sato; Tadashi Kawakami
Journal:  Am J Med Genet A       Date:  2008-06-01       Impact factor: 2.802

9.  Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium).

Authors:  Eric M Graham; Scott M Bradley; Girish S Shirali; Christine B Hills; Andrew M Atz
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778

10.  Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk.

Authors:  B J Baty; B L Blackburn; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15
View more
  4 in total

1.  Cardiovascular surgery for congenital heart disease associated with trisomy 18.

Authors:  Hiroyuki Yamagishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-05-07

Review 2.  Ethical issues about the paradigm shift in the treatment of children with trisomy 18.

Authors:  Agustín Silberberg; Josefina Robetto; Guadalupe Grimaux; Laura Nucifora; José Manuel Moreno Villares
Journal:  Eur J Pediatr       Date:  2019-12-09       Impact factor: 3.183

3.  A contemporary, single-institutional experience of surgical versus expectant management of congenital heart disease in trisomy 13 and 18 patients.

Authors:  John P Costello; Allison Weiderhold; Clauden Louis; Conner Shaughnessy; Syed M Peer; David Zurakowski; Richard A Jonas; Dilip S Nath
Journal:  Pediatr Cardiol       Date:  2015-01-23       Impact factor: 1.655

4.  Clinical features and survival in individuals with trisomy 18: A retrospective one-center study of 44 patients who received intensive care treatments.

Authors:  George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Mol Med Rep       Date:  2016-01-22       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.